Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptorcancernews.com...
Research on biomarker-driven therapy and immune check-point blockade in non-small cell lung cancer (NSCLC) is rapidly evolving. The width and depth of clinical trials have also dramatically improved in an unprecedented speed. The personalized treatment paradigm evolved every year. In this review, w...
BIOMARKERSGENOMESSEQUENCE analysisLung cancer is one of the most common malignant tumors in the world, of which non-small cell lung cancer (NSCLC) is the majority. The emergence of immune checkpoint inhibitors (ICIs) has greatly changed the treatment strategy of...
Volume: 57, P: 281-282 Integration of novel biomarkers in prospective trials: biological insights from CHOICE-01 Edward Christopher Dee Puneeth Iyengar Research HighlightsOpen Access05 Dec 2024Signal Transduction and Targeted Therapy Volume: 9, P: 356 Nature.com...
Impact of biomarkers on clinical trial risk in breast cancer We determined the success rate of new drug approval by the US FDA in two breast cancer indications, one of which used a biomarker. This allowed us to asses... JL Parker,N Lushina,PS Bal,... - 《Breast Cancer Research & Trea...
Although the research on lung cancer biomarkers has advanced significantly in recent years, most studies use multivariate statistical analysis to analyze targeted metabolites. In this article, we analyze all metabolites from plasma using non-targeted metabolomics to search the biomarkers related to lung ...
immunotherapies is an exciting research area and needs further investigation. This review highlights the role of TEXs as key contributors to the advancement of lung cancer and their clinical significance in lung immune-oncology, including their possible use as biomarkers for monitoring disease ...
The application of AI in several domains is now associated with great expectations and at the same time exists a great vacancy in cancer research especially lung cancer. In this study, the major aim of metabolomics research on lung cancer was to discover clinical metabolic biomarkers that had ...
Effect of Asymmetric Tension on Biomechanics and Metabolism of Vertebral Epiphyseal Plate in a Rodent Model of Scoliosis 2017, Orthopaedic Surgery Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819 2012, Clinical Cancer Research Translating biomarkers to clinical practi...
Our Lung Cancer Expert Dasha Kaloujskaia, is the lead research analyst for Biomarkers & Assays related trials and assays in the Beaconteam. Interested in a tour? Contact us For a tour of the Beacon Biomarkers & Assays database, please contact the team below. ...